Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration

被引:53
作者
Tredici, G
Tredici, S
Fabbrica, D
Minoia, C
Cavaletti, G
机构
[1] Univ Milan, Ist Anat Umana, Milan, Italy
[2] Univ Milan, Clin Neurol 5, Monza, Italy
[3] IRCCS, Clin Lavoro Riabilitaz, Fondaz S Maugeri, Pavia, Italy
关键词
cisplatin neuronopathy; dorsal root ganglia; nerve conduction velocity; retinoic acid; neuroprotection; nerve recovery;
D O I
10.1023/A:1005756023082
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peripheral nervous system alterations were induced in adult rats by administration of cisplatin (CDDP) 2 mg/kg twice weekly for 4.5 weeks. Dorsal root ganglion neurons showed pathological changes. Morphometric determinations demonstrated a reduction in size of the somatic, nuclear and nucleolar area. The nucleoli were the most involved subcellular structures. Nerve conduction velocity and the tail-flick test for pain were both significantly altered in CDDP treated rats, whereas the rota-rod test for coordination revealed no changes in either treated or control rats. Analytical determinations demonstrated platinum accumulation in the DRG of CDDP treated rats. Spontaneous recovery, demonstrated by morphometric, electrophysiological, functional and analytical determinations, occurred after treatment discontinuation within about 7 weeks. A pilot study of the possible neuroprotective action of retinoic acid (RA) was also performed with this model of cisplatin neuronopathy. The rationale for using RA was based on its assumed antioxidant and neurotrophic effect. However, RA failed to prevent morphometric, electrophysiological, functional and analytical alterations induced by CDDP on DRG neurons. RA induced only a mild generalized protective effect.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 59 条
[21]   PUTATIVE NEUROTROPHIC FACTORS IN THE PROTECTION OF CISPLATIN-INDUCED PERIPHERAL NEUROPATHY IN RATS [J].
HAMERS, FPT ;
VANDERHOOP, RG ;
STEERENBURG, PA ;
NEIJT, JP ;
GISPEN, WH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 111 (03) :514-522
[22]   INHIBITORY EFFECTS OF ANTI-TUMOR PLATINUM COMPOUNDS ON DNA, RNA AND PROTEIN SYNTHESES IN MAMMALIAN CELLS IN-VITRO [J].
HARDER, HC ;
ROSENBERG, B .
INTERNATIONAL JOURNAL OF CANCER, 1970, 6 (02) :207-+
[23]   EFFECT OF RETINOIC ACID ON NERVE GROWTH-FACTOR RECEPTORS [J].
HASKELL, BE ;
STACH, RW ;
WERRBACHPEREZ, K ;
PEREZPOLO, JR .
CELL AND TISSUE RESEARCH, 1987, 247 (01) :67-73
[24]   CHEMICAL-REACTIVITY OF CISPLATIN BOUND TO HUMAN-PLASMA PROTEINS [J].
HEGEDUS, L ;
VANDERVIJGH, WJF ;
KLEIN, I ;
KERPELFRONIUS, S ;
PINEDO, HM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (03) :211-212
[25]  
HENNEKENS CH, 1986, CANCER-AM CANCER SOC, V58, P1837, DOI 10.1002/1097-0142(19861015)58:8+<1837::AID-CNCR2820581409>3.0.CO
[26]  
2-X
[27]   PROTECTION BY AN ACTH(4-9) ANALOG AGAINST THE TOXIC EFFECTS OF CISPLATIN AND TAXOL ON SENSORY NEURONS AND GLIAL-CELLS IN-VITRO [J].
HOL, EM ;
MANDYS, V ;
SODAAR, P ;
GISPEN, WH ;
BAR, PR .
JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 39 (02) :178-185
[28]   THE COURSE OF NEUROPATHY AFTER CESSATION OF CISPLATIN TREATMENT, COMBINED WITH ORG-2766 OR PLACEBO [J].
HOVESTADT, A ;
VANDERBURG, MEL ;
VERBIEST, HBC ;
VANPUTTEN, WLJ ;
VECHT, CJ .
JOURNAL OF NEUROLOGY, 1992, 239 (03) :143-146
[29]   SOLUTION STRUCTURE OF A CISPLATIN-INDUCED DNA INTERSTRAND CROSS-LINK [J].
HUANG, HF ;
ZHU, LM ;
REID, BR ;
DROBNY, GP ;
HOPKINS, PB .
SCIENCE, 1995, 270 (5243) :1842-1845
[30]   ANTIOXIDANT EFFECT OF RETINOIC ACID ON PC12 RAT PHEOCHROMOCYTOMA [J].
JACKSON, GR ;
MORGAN, BC ;
WERRBACHPEREZ, K ;
PEREZPOLO, JR .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1991, 9 (02) :161-170